A prospective cohort study in people living with HIV (PLWH) assessing reduction in T cell exhaustion, which is preserved after switching to a new therapy regimen
Latest Information Update: 28 Dec 2021
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary) ; Dolutegravir/lamivudine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 28 Dec 2021 New trial record
- 30 Oct 2021 Results presented at the 18th European AIDS Conference